'Miss­ing link': Bay­er, Morn­ing­side help cat­a­pult a new kind of de­liv­ery tech to cell and gene ther­a­py

Robert Mill­man co-found­ed and led Sem­ma Ther­a­peu­tics as CEO while al­so a man­ag­ing di­rec­tor of MPM Cap­i­tal. By the time he left the stem cell ther­a­py pi­o­neer — two years be­fore it would be sold to Ver­tex — he had left VC life be­hind.

In­stead, he went around scout­ing new tech­nolo­gies, vis­it­ing with tech trans­fer of­fices and aca­d­e­mics in the Boston/Cam­bridge area to find wor­thy ideas that could ben­e­fit from his IP ex­per­tise.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

Vice President

Alexandria Real Estate Equities

San Francisco, CA, USA